FDA approved 50% more Digital Therapeutics (DTx) in 2023 compared to 2022.
Nerivio is a wearable device for migraine treatment, utilizing remote electrical neuromodulation.
Lenire received FDA De Novo approval as a pioneering tinnitus treatment device.
Somryst is the first FDA-approved DTx for chronic insomnia.
ReSET and ReSET-O are FDA-cleared DTx for substance use disorders.
Get more accurate answers with Super Search, upload files, personalized discovery feed, save searches and contribute to the PandiPedia.
Let's look at alternatives: